El papel de los probióticos en la prevención de las infecciones urinarias recurrentes en mujeres

  1. Jiménez Pacheco, Antonio
  2. Jiménez Pacheco, Araceli
  3. Moral Domínguez, E. del
Zeitschrift:
Actualidad médica

ISSN: 0365-7965

Datum der Publikation: 2013

Band: 98

Nummer: 788

Seiten: 45-49

Art: Artikel

DIALNET GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Actualidad médica

Zusammenfassung

Introduction: Urinary tract infections (UTI) are among the most prevalent infectious diseases. Antibiotics used for treatment and prevention of recurrences generate significant healthcare cost and disruption of the vaginal microbiota, which has led them to seek alternative therapies, including the probióticos enters. The aim of the study is to analyze the role of probiotics in the prevention of recurrent UTIs in women. Material and methods: We searched the PUBMED database of articles published up to January 2013, with the terms �probiotics and urinary tract infection�, obtaining 66 items of which 37 items finally selected. Results: Of the 37 items, 25 are literature reviews, 6 randomized trials, controlled and other pilot studies and case-control prospective. Was compared the administration of Lactobacillus versus trimethoprim-sulfamethoxazole (TMP / SMX) noting that Lactobacillus does not meet the criteria for non-inferiority in preventing UTIs compared with TMP / SMX. Also compared cranberry juice consumption against Lactobacillus, observing a decrease in the number of recurrences in the group taking cranberry. In studies that compared placebo vs Lactobacillus if there has been a 50-70% reduction in the number of recurrences compared to placebo. Conclusions: Although most studies are heterogeneous and small sample size, the use of certain Lactobacillus strains for preventing recurrences of UTI is promising.

Bibliographische Referenzen

  • Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections—a systematic review. J Chemother. 2009; 21:243-52.
  • Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care. 1994; 12:239-43.
  • Barbés C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS. 1999; 13:747-51.
  • Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther. 2008; 30:453-68.
  • Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012; 172:704-12.
  • Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, et al. Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol. 2008; 24:139-44.
  • Bruce AW, Reid G. Bruce AW, Reid G. Probiotics and the urologist. Can J Urol. 2003; 10:1785-9.
  • Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol. 2009; 60 Suppl 6:13-8.
  • Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003; 5(11):767-9.
  • Coppens P, Fernandes da Silva M, Pettman S. European regulations on nutroceuticals, dietary supplements and functional foods: A framework based on safety. Toxicology 2006; 221: 59-74.
  • Elmer GW. Probiotics: “living drugs”. Am J Health Syst Pharm. 2001; 58:1101-9.
  • Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs. 2006; 66:1253-61.
  • Foxman B, Barlow R; D´Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated cost. Ann Epidemiol 2000; 10: 509-15.
  • Hoesl CE, Altwein JE. The Probiotic Approach: An Alternative Treatment Option in Urology. Eur Urol 2005; 47: 288-96.
  • Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001; 17:259-68.
  • Juárez Tomás MS, Saralegui Duhart CI, De Gregorio PR, Vera Pingitore E, Nader-Macías ME. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates. Eur J Obstet Gynecol Reprod Biol. 2011; 159:399-406.
  • Kontiokari T, Laitinen J, Järvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003; 77:600-4.
  • Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001; 322:1571.
  • Martín R, Soberón N, Vázquez F, Suárez JE. Vaginal microbiota: composition, protective role, associated pathologies, and therapeutic perspectives. Enferm Infecc Microbiol Clin. 2008; 26:160-7.
  • McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011; 86:58-64.
  • Miller JL, Krieger JN. Urinary tract infections cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am. 2002; 29:695-9.
  • Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistanse. Mayo Clin Proc 2004; 79; 1048-54.
  • Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt) 2012; 21:347-54.
  • Parkes GC. An overview of probiotics and prebiotics. Nurs Stand. 2007; 21:43-7.
  • Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001; 30:49-52.
  • Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev. 1990; 3:335-44.
  • Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992; 14:11-6.
  • Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995; 23: 32–45.
  • Reid G, Bruce AW. Could probiotics be an option for treating and preventing urogenital infections?. Medscape Womens Health. 2001; 6:9.
  • Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006; 24:28-32.
  • Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2011; 183: 77-80.
  • Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003; 79:428-32.
  • Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. MedGenMed. 2004; 6:49.
  • Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002; 4:319-24.
  • Reid G, Dols J, Miller W. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care. 2009; 12:583-7.
  • Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol. 1999; 17:359-63.
  • Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr. 2001; 73:437S-443S.
  • Reid G. Probiotic Therapy and Functional Foods for Prevention of Urinary Tract Infections: State of the Art and Science. Curr Infect Dis Rep. 2000; 2:518-522.
  • Reid G. Probiotics for urogenital health. Nutr Clin Care. 2002; 5:3-8.
  • Reid G. The role of cranberry and probiotics in intestinal and urogenital tract health. Crit Rev Food Sci Nutr. 2002; 42:293-300.
  • Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2012; 11:CD009279.
  • Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52:1212-7.
  • Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents. 2006; 28 Suppl 1:S30-4
  • Waigankar SS, Patel V. Role of probiotics in urogenital healthcare. J Midlife Health. 2011; 2 5-10.
Fuente de los datos: Dialnet